1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Epiomic Epidemiology Series: Behcet’s Disease Forecast in 12 Major Markets 2016-2026

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Behcet’s Disease in 12 Major Markets

Behçet's disease (BD), also known as Silk Road Disease or Adamantiades-Behçet’s Disease, is a rare disease classified amongst a group of disorders termed “vasculitides”. The pathophysiology is thought to be autoimmune, linked to the HLA-B5/51 antigen. As a multisystem disease, clinical manifestations can involve nearly all systems of the body. The manifestations are self-limiting but recurrent and thus the majority of BD is characterized by a relapsing-remitting pattern.

This report provides the current prevalent population for Behcet’s disease across 12 Major Markets (USA, France, Germany, Italy, Spain, UK, Japan, Sweden, Turkey, China, Saudi Arabia and Egypt) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Behcet’s disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Behcet’s disease include:

• Skin involvement with or without Erythema Nodosum
• Genital ulcers
• Eye involvement with or without Uveitis
• Arthritis
• CNS involvement
• Vascular involvement

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Behcet’s disease’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Behcet’s disease and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Behcet’s disease’s prevalent population.
• Identify sub-populations within Behcet’s disease which require treatment.
• Gain an understanding of the specific markets that have the largest number of Behcet’s disease patients.

Table Of Contents

Epiomic Epidemiology Series: Behcet’s Disease Forecast in 12 Major Markets 2016-2026
Table of Contents
- List of Tables and Figures
- Introduction
- Cause of the Disease
- Risk Factors and Prevention
- Diagnosis of the Disease
- Variation by Geography/Ethnicity
- Disease Prognosis and Clinical Course
- Key Co-morbid Conditions /Features Associated with the Disease
- Methodology for Quantification of Patient Numbers
- Top-Line Prevalence for Behcet's Disease
- Antigens and Pathergy in Bechet's Disease Patients
- Clinical Features of Bechet's Disease Patients
o Skin Manifestations
o Ocular Manifestations
o Joint Manifestations
o CNS Manifestations
o Vascular Manifestations
o Cardiac Manifestations
o Gastrointestinal Manifestations
- Abbreviations used in the Report
- Other Black Swan Analysis Publications
- Black Swan Analysis Online Patient-Based Databases
- Patient-Based Offering
- Online Pricing Data and Platforms
- References
- Appendix


List of Tables

- International Study Group guidelines for diagnosis
- The ICBD criteria
- Prevalence of Behçet's Disease, total
- Prevalence of Behçet's Disease, males
- Prevalence of Behçet's Disease, females
- BD patients that are HLA-B5/51 positive, total patients
- BD patients with positive Pathergy test, total patients
- BD patients with erythema nodosum, total patients
- BD patients with folliculitis, total patients
- BD patients with papulopustular lesions, total patients
- BD patients with genital ulcers, total patients
- BD patients with uveitis, total patients
- BD patients with hypopyon iritis, total patients
- BD patients with retinitis, total patients
- BD patients with visual loss and blindness, total patients
- BD patients with arthritis, total patients
- Neurological involvement in BD, total patients
- Course of the neurological involvement in BD, total patients
- Acute neurological with single episode, total patients
- Acute neurological with relapsing-remitting pattern, total patients
- Chronic neurological, primary progressive, total patients
- Chronic neurological, progressive with further relapses, total patients
- Cerebral haemorrhage in BD patients with neurological involvement, total patients
- Vascular involvement in BD, total patients
- DVT in BD, total patients
- Superficial thrombophlebitis in BD, total patients
- Cardiac involvement in BD, total patients
- Gastrointestinal (GI) involvement in BD, total patients
- Bowel perforation in BD patients with GI involvement, total patients
- Abbreviations and acronyms used in the report
- USA Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- USA Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- France Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- France Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Germany Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Germany Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Italy Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Italy Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Spain Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Spain Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- United Kingdom Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- United Kingdom Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Sweden Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Sweden Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Turkey Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Turkey Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Japan Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Japan Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- China Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- China Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Saudi Arabia Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Saudi Arabia Prevalence of Behcet's disease by 5-yr age cohort, females (000s)
- Egypt Prevalence of Behcet's disease by 5-yr age cohort, males (000s)
- Egypt Prevalence of Behcet's disease by 5-yr age cohort, females (000s)


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune ...

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Brain Injury in 21 Major Markets Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing ...

Epiomic Epidemiology Series: HIV Forecast in 8 Major Markets 2016-2026

Epiomic Epidemiology Series: HIV Forecast in 8 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • September 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on HIV in 8 Major Markets The human immunodeficiency virus (HIV) is a lentivirus that causes chronic viral infection. HIV damages the ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.